Discontinued — last reported Q3 '18
DuPont de Nemours, Inc. Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) decreased by 35.9% to $209.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 44.1%, from $374.00M to $209.00M. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $572.00M | $490.00M | $482.00M | $471.00M | $425.00M | $422.00M | $476.00M | $419.00M | $418.00M | $430.00M | $374.00M | $379.00M | $326.00M | $209.00M |
| QoQ Change | — | -14.3% | -1.6% | -2.3% | -9.8% | -0.7% | +12.8% | -12.0% | -0.2% | +2.9% | -13.0% | +1.3% | -14.0% | -35.9% |
| YoY Change | — | — | — | -17.7% | -13.3% | -12.4% | +1.1% | -1.4% | -0.9% | -9.7% | -10.7% | -9.3% | -24.2% | -44.1% |